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Cytolethal distending toxins (CDT) are considered the prototype of inhibi-
tory cyclomodulins, and are produced by a wide range of Gram-negative patho-
genic bacteria, including Escherichia coli strains of various sero- and pathotypes. 
CDT is a heterotripartite toxin consisting of three protein subunits, CdtA, CdtB and 
CdtC. The active subunit, CdtB has DNase activity and causes DNA damage and 
cell cycle arrest in the target cell. However, several studies have highlighted dif-
ferent roles for CdtA and CdtC subunits. In order to reveal the necessity of CdtA 
and CdtC subunit proteins in the CDT-specific phenotype, expression clones con-
taining the cdt-V subunit genes were constructed. Using cell culture assays, we 
demonstrated that clones expressing only the CdtB subunit or in combination with 
only CdtA or CdtC were unable to trigger the specific cell cycle arrest and changes 
in cell morphology in HeLa cells. At the same time, the recombinant clone har-
bouring the whole cdt-V operon caused all the CDT-associated characteristic phe-
notypes. All these results verify that all the three CDT subunit proteins are neces-
sary for the genotoxic effect caused by CDT-V. 
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Cytolethal distending toxins (CDT) establish a family of toxins with 
emerging importance in pathogenic Escherichia coli and numerous other Gram-
negative pathogenic bacteria (reviewed by Gargi et al., 2012) and are considered 
the prototypic family of inhibitory cyclomodulins (Nougayrède et al., 2005; 
Oswald et al., 2005). 
Five types of CDT (CDT-I to CDT-V) have been reported in pathogenic 
E. coli strains (Tóth et al., 2009a); among them CDT-V is the most recently 
identified (Janka et al., 2003), and the only type to be detected in Shiga toxin 
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producing (STEC) and enterohaemorrhagic (EHEC) E. coli (Orth et al., 2006; 
Hinenoya et al., 2009; Hinenoya et al., 2014). Additionally, CDT-V has been de-
tected in several strains of uncertain pathotype (Hinenoya et al., 2009; Tóth et al., 
2009b), and in some of these strains it is the only identified toxin so far (Tóth et 
al., 2009b). 
Most CDTs form a heterotripartite complex of three subunits, CdtA, CdtB, 
and CdtC (Gargi et al., 2012). Among them CdtB has DNase activity (Elwell and 
Dreyfus, 2000), causing DNA damage in the target cell’s nucleus, which, 
through the DNA damage response (DDR) mechanisms, ultimately causes cell 
cycle arrest between the G2/M phase and the characteristic transformation of the 
intoxicated cells into giant, elongated mononuclear cells (Comayras et al., 1997; 
Pérès et al., 1997; Bielaszewska et al., 2005). In the case of cells with fibroblast 
origin, the cell cycle arrest occurs in the G1/S phase (Belibasakis et al., 2004). 
The proposed role of CdtA and CdtC is the transport of CdtB to the target 
cell and the attachment of the toxin to the cell surface, and it has been verified in 
the case of Campylobacter jejuni (Lara-Tejero and Galán, 2001) and Aggregati-
bacter actinomycetemcomitans (Nesić et al., 2004; Yamada et al., 2006). How-
ever, there is increasing evidence suggesting that despite the similar genotoxic 
activity, there are differences between the molecular mechanisms used by the 
different CDT types in interaction with the host cell (McSweeney and Dreyfus, 
2005; Eshraghi et al., 2010; Gargi et al., 2013). The exact role of the CdtA and 
CdtC subunits is not well understood in the case of E. coli CDT, and no data are 
available regarding their roles in CDT type V. 
The aim of the present study was to assess the roles of the individual 
CDT-V subunits by cloning the cdt-V genes into an expression vector in different 
combinations, and evaluating the CDT-specific effect of the clones on tissue cul-
tures. 
 
Materials and methods 
Bacterial strains and human cell cultures. The atypical (stx– and eae–) E. 
coli O157:H43 strain T22 carrying the cdt-V operon (Tóth et al., 2009b) was 
used as donor of cdt genes. The E. coli K-12 strain BL21(DE3) was used as re-
cipient for the cloned constructs. HeLa (ATCC CCL-2) cells were maintained by 
serial passage in Dulbecco’s Modified Eagle medium (DMEM GlutaMAX™, 
Gibco), supplemented with 10% fetal calf serum (FCS), non-essential amino ac-
ids (Gibco) and 50 µg ml–1 gentamicin at 37 °C in a 5% CO2 atmosphere. 
Construction of clones carrying cdt subunit genes. Recombinants were 
constructed using PCR-amplified CDT subunit genes in combinations of ABC, 
AB, BC and B from the cdt-V genes of E. coli O157:H43 strain T22. The primers 
used for amplification were designed to match the very first and last bases of the 
start and stop codons of the respective genes, carried cleavage sites of EcoRI or 
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XhoI, and three timins on the 5’ end to facilitate annelation, based on the se-
quence of the cdt-V operon of the strain determined in an earlier study (Sváb et 
al., 2013; Table 1). All reactions were performed using Platinum Taq HiFi 
(Sigma-Aldrich, St. Louis, MO, USA), with an annealing temperature of 42 °C. 
PCR fragments were purified with GenElute PCR Clean-up Kit (Sigma-Aldrich, 
St. Louis, MO, USA). The proper PCR fragments as well as the pET28b expres-
sion vector were digested with the appropriate endonucleases and were ligated by 
T4 ligase (Fermentas, Vilnius, Lithuania) for 1 h at room temperature. Compe-
tent cells of the recipient bacterial strain were transformed by electroporation. 
Transformants were selected by growing on lysogeny broth (LB) agar plates 
supplemented with 25 μg ml–1 kanamycin as a selective agent. Resistant clones 
were tested by PCR and plasmid analysis. 
Table 1 
Primers used for amplifying cdt-V genes for cloning 
Primer name Target gene Sequence 5' -> 3' 
CDTAfwEcorI cdtA TTTGAATTCAATGGCTAATAAATACACACC 
cdtA_rev_xhoi cdtA TTTCTCGAGTTATTACAGTCCTGTTTATGA 
cdtbfw_ecori cdtB TTTGAATTCATGAAAAAATATATTATATC 
cdtbrev_xhoi cdtB TTTCTCGAGTTATCGTCTGGAAACGCCAA 
cdtcfw_ecori cdtC TTTGAATTCATGAAGAGATTAATAATTAT 
cdtcrev_xhoi cdtC TTTCTCGAGTTAAATAATAGGCGATTCAG 
All primers were designed for this study based on GenBank sequence no. KC618326.1 
(Sváb et al., 2013). The restriction sites of EcoRI and XhoI are underlined. All PCRs were run 
with an annealing temperature of 42 °C, as described in the Materials and methods section 
 
Biomass measurement assays. Ten ml of LB culture of BL21DE3 express-
ing the different combinations of CDT subunits were incubated at 37 °C with 
vigorous shaking until the optical density (OD) reached 0.5 to 0.6 before 3-h in-
duction with 0.5 mM of IPTG. Supernatant was 0.22 µm filtered and was con-
centrated to 250 µl using a centrifugal concentrator (10 kDa cut-off, Vivaspin). 
Concentrated supernatant was serially diluted 2 times in a 96-well microplate and 
100 µl of diluted sample were added to HeLa cells cultivated in a 96-well culture 
microplate (30,000 HeLa cells per well) in 100 µl of DMEM supplemented with 
10% FCS. Quantification of biomass was performed as previously described (De 
Rycke et al., 1996). After 3 days of culture, cells were fixed with 3.7% formal-
dehyde in PBS and then stained with a 1% (w/v) solution of methylene blue in 
borate buffer for 10 min. After five washes in borate buffer, methylene blue was 
extracted with 0.1 M HCl and the OD of the staining solution was read at 660 nm 
in a microplate reader. Alternatively, cells were stained with Giemsa stain solu-
tion (Sigma) for microscopic examination according to the manufacturer’s proto-
col after 3 days of culture. 
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Flow cytometry assays. Cell cycle analysis was performed as previously 
described (Taieb et al., 2006). Six hundred thousand HeLa cells were treated 
with 1:10 dilution of concentrated supernatant or with purified CDT-I for 24 h 
(Taieb et al., 2006). Cells were then trypsinised, resuspended in PBS and fixed in 
70% ethanol overnight at –20 °C. Cells were washed and resuspended in PBS 
containing 15 mg ml–1 propidium iodide and 100 mg ml–1 RNase A. Flow cy-
tometry analyses were performed on a FACScalibur flow cytometer (Becton 
Dickinson). Data were analysed using FlowJo software (Tree Star). Percentage 
of G1, S and G2 populations were calculated using the Watson-pragmatic and the 
Dean-Jett-Fox models. 
Western blot analysis. Experiments were performed as described previ-
ously (Taieb et al., 2006). For western blot analysis of total proteins, 4–8 × 105 
HeLa cells exposed to supernatants of study strains were lysed in 80 μl of 1× 
Laemmli loading buffer, sonicated for 5 s to shear DNA, then boiled for 5 min. 
Proteins were separated on 4–12% NuPage gradient gels (Invitrogen) and trans-
ferred to PVDF membranes. The membranes were blocked in 10 mM Tris pH 
7.8, 150 mM NaCl, 0.1% Tween 20 (TBST), 10% non-fat dry milk, then probed 
with primary antibody (0.5 µg/ml) in TBST, 5% non-fat dry milk. The primary 
antibodies were anti-phosphorylated H2AX (pH2AX) (Upstate), anti-
phosphorylated CDK1 (pY15, Cell Signalling Technology), and anti-actin (ICN) 
antibodies. Bound antibodies were visualised with horseradish peroxidase-
conjugated secondary antibody. Acquisitions were performed with a Molecular 
Imager Chemi Doc XRS System (Bio-Rad). 
 
 
Results 
HeLa cell biomass assays. In order to investigate the function of CDT-V 
subunit proteins, we inserted the genes encoding CdtA, CdtB and CdtC proteins 
into pET28b expression vectors and constructed clones of the E. coli K-12 strain 
BL21(DE3). The genes were cloned in the following combinations: cdt-V ABC, 
cdt-V AB, cdt-V BC and cdt-V B. 
Hela cells were exposed to serial dilutions of the concentrated super-
natants of the clones. The greatest decrease of biomass could be observed in cul-
tures exposed to the supernatant of the cdt-VABC clone, followed by the cultures 
treated with supernatants of the cdt-VAB and cdt-VBC clones, respectively. In the 
two latter cases, decrease in biomass could also be observed at higher dilutions, 
when compared to the controls and to the cells treated with the supernatant of the 
cdt-VB clone (Fig. 1A), albeit to a considerably lesser extent than in the case of 
cdt-V ABC. Morphological changes were monitored by light microscopy, and cy-
topathic effect was evident with cell distension for HeLa cells intoxicated only 
with the supernatant fraction of the culture expressing the three subunits, 
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whereas other combinations of CDT-V subunits did not exhibit such distending 
activity (Fig. 1B). 
CDT-specific effects of clones on the cell cycle of HeLa cells. To further 
explore the mode of action of CDT-V subunit proteins, HeLa cells were incu-
bated in the presence of the culture supernatant of BL21(DE3) E. coli cells con-
taining pET28 vector expressing the four gene combinations described. Purified 
standard amount of CDT-I was used as positive control (Taieb et al., 2006). 
Twenty-four h after treatment, cell cycle distribution was analysed by flow cy-
tometry. Our results showed that the clone with the cdt-V ABC expressed a func-
tional CDT that induced accumulation of cells in the G2-phase or mitosis (M-
phase) with a 4n DNA content (37% versus 12% in control cells), albeit with a 
reduced titre when compared to the purified CDT protein used as control (Fig. 
2A). The other constructs expressing a combination of two CDT subunits (AB or 
BC) or B subunit alone did not cause cell cycle arrest (with a population of cells in 
G2 and M phases ranging from 15% to 16%) as compared to the control culture. 
To further characterise the CDT-V induced cell cycle arrest, we examined 
the phosphorylation status of the eukaryotic inducer of the G2 to M phases tran-
sition, the CDK1-cyclin B complex. Western blot analysis showed that purified 
CDT-I as well as CDT-V ABC prevented entry in mitosis by maintaining CDK1 
in its inhibitory phosphorylated form, indicating that cells are arrested in the G2-
phase (Fig. 2B). Moreover, we observed phosphorylation of histone H2AX, a 
sensitive marker of DNA double strand breaks (DSBs), only in cultures exposed 
to the supernatant of the clone expressing cdt-V ABC (Fig. 2B). Taken together, 
these results show that CDT-V induces DSBs that result in activation of the DNA 
damage response, which eventually leads to inhibition of the mitosis inducer, 
CDK1 and subsequent accumulation of cells in the G2 phase. 
 
 
Discussion 
In the case of CDT-V produced by E. coli, the roles of individual CDT 
protein subunits in the cytotoxic effect were unknown. Using clones expressing 
the subunit genes of E. coli CDT-V in different combinations, we have found 
that, besides the active B subunit, the A and C subunits are both necessary to in-
duce the characteristic cell cycle arrest and distended cell morphology, as the 
clones lacking any of the CDT-V subunit proteins were unable to cause these 
specific effects. As expected, we showed that CDT activity was related to its de-
scribed DNase activity as treated cells exhibited DNA double strand breaks. We 
also revealed that CDT-V-associated double strand breaks activated the DNA 
damage response, leading to CDK1 inhibitory phosphorylation and subsequent 
cell cycle arrest. 
 
 Acta Veterinaria H
ungarica 63, 2015 
6 
TA
IEB
 et al.
 
 
Fig. 1. Cytopathic effect of CDT-V ABC in HeLa cells. (A) Biomass of HeLa cells after 3-day exposure to serial dilutions of the supernatant of 
BL21(DE3) expressing the indicated CDT subunits. Biomass was expressed as absorbance of methylene blue. (B) HeLa cells exposed as in (A) 
with supernatant of the indicated clones and stained with Giemsa. Bars represent 100 µm. Characteristic distended cells are visible when treated 
with the supernatant containing CDT-V ABC 
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Fig. 2. CDT induces cell cycle arrest and DNA double strand breaks. HeLa cells were treated with supernatant of BL21(DE3) (10–1 dilution) ex-
pressing the indicated CDT subunits for 24 h and analysed for DNA content by flow cytometry following propidium staining. Percentages of cells 
in G2/M were calculated using Dean-Jett-Fox model and reported in the right panel. HeLa cells were treated as in (A) and protein extracts were 
probed with anti-phosphorylated H2AX (pH2AX), anti-phosphorylated CDK1 (pCDK1) and anti-actin antibodies 
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Although the heterotripartite model of the toxin has been confirmed in 
multiple cases (Nougayrède et al., 2005; Oswald et al., 2005; Tóth et al., 2009a; 
Gargi et al., 2012), there have been cases where the authors reported characteris-
tic CDT activity in the case of CDTs missing either the A or C subunit, as with 
the CDT produced by Aggregatibacter actinomycetemcomitans (De Rycke et al., 
1996; Taieb et al., 2006). The Aggregatibacter CDT was found to be functional, 
albeit with a reduced titre, when lacking the A (Akifusa et al., 2001) or the C 
subunit (Saiki et al., 2001). These findings were later explained by the work of 
Damek-Poprawa et al. (2012) who reported that after the internalisation of CdtB, 
CdtA remains on the cell surface, while CdtC migrates into the cytosol, suggest-
ing that it acts as a chaperone to CdtB. In the present study, the slight decrease in 
cell mass observable in HeLa cultures after 3 days of exposure to supernatants 
containing CdtB + CdtC combination, and more noticeably in the case of CdtB + 
CdtA, might suggest similar mechanisms. 
The CDT produced by Haemophilus ducreyi was found to exhibit a slight 
activity when lacking the A subunit (Deng et al., 2001), although the molecular 
background of this discrepancy has not been elaborated yet. In the case of this 
CDT type, when compared to the CDT produced by E. coli, Gargi et al. (2013) 
found that while endosome acidification inhibits the transport of H. ducreyi CdtB 
to the nucleus, E. coli CdtB is unaffected by this change, suggesting different  
intracellular pathways for the B subunit in the case of these two toxin types. It is 
noteworthy that Salmonella Typhi, which does not express either CdtA or CdtC 
subunits, uses a bacterial internalisation pathway to deliver the enzymatic CdtB 
subunit directly into the host cell (Haghjoo, 2004). These findings indicate that 
while the general model of CDT function may be correct, the key molecules that 
the subunit proteins interact with, and the pathways they take in the target cells 
may be different, and therefore should be investigated carefully in each CDT type. 
Our study confirmed that in the case of E. coli CDT-V, as with other in-
vestigated CDT types (Lara-Tejero and Galán, 2001), both CdtA and CdtC are 
necessary for the toxin to be fully functional. However, as recent studies revealed 
considerable differences between the potential receptors of different CDT types, 
and between the potential roles of the subunit proteins, an important future task 
will be to determine the specific receptors responsible for the attachment of 
CDT-V to the target cell membrane, as well as the localisations of individual 
CDT-V subunits during the intoxication of target cells. 
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